We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

81 hedge funds and large institutions have $84.8M invested in Enzo Biochem, Inc. in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more call options, than puts

Call options by funds: $19K | Put options by funds: $1K

4% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 24

7% less funds holding

Funds holding: 87 → 81 (-6)

28% less capital invested

Capital invested by funds: $117M → $84.8M (-$32.7M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
81
Holders Change
-6
Holders Change %
-6.9%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
5
Increased
25
Reduced
24
Closed
11
Calls
$19K
Puts
$1K
Net Calls
+$18K
Net Calls Change
-$19K

Top Buyers

Rank Fund Capital Flow
1
FM
Fondren Management
Texas
+$1.11M
2
Renaissance Technologies
Renaissance Technologies
New York
+$162K
3
Morgan Stanley
Morgan Stanley
New York
+$140K
4
PAM
Panagora Asset Management
Massachusetts
+$117K
5
Millennium Management
Millennium Management
New York
+$114K

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$734K
2
MCM
Marathon Capital Management
Maryland
-$478K
3
N
Nuveen
North Carolina
-$427K
4
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
-$288K
5
AI
Ariel Investments
Illinois
-$181K
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
76
Ladenburg Thalmann Financial Services
Florida
$1K – – –
EI
77
EAM Investors
California
– -$734K -203,962 Closed
DGHMC
78
Dalton, Greiner, Hartman, Maher & Co
New York
– -$288K -80,000 Closed
KBC Group
79
KBC Group
Belgium
– -$168K -46,734 Closed
ARTA
80
A.R.T. Advisors
New York
– -$84K -23,399 Closed
CS
81
Credit Suisse
Switzerland
– -$49K -13,672 Closed
Marshall Wace
82
Marshall Wace
United Kingdom
– -$45K -12,465 Closed
CCP
83
Corient Capital Partners
California
– -$43K -11,831 Closed
Connor, Clark & Lunn Investment Management (CC&L)
84
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$40K -11,175 Closed
Los Angeles Capital Management
85
Los Angeles Capital Management
California
– -$36K -10,084 Closed
Victory Capital Management
86
Victory Capital Management
Texas
– -$25K -7,060 Closed
QT
87
Quantamental Technologies
New York
– -$6K -1,699 Closed
OSAM
88
O'Shaughnessy Asset Management
Connecticut
– +$3 +1 New
1 2 3
4

ENZ Hedge Fund Activity: Q4 2019 in Review

81 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q4 2019, worth a combined $84.8M — down 28% from $117M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ENZ and 5 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 25 added.

The largest buyer was Fondren Management, adding an estimated $1.11M. The largest seller was EAM Investors, exiting entirely with an estimated $734K sold.

  • 81 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q4 2019, down from 87 in Q3 2019.
  • Funds reported $84.8M of Enzo Biochem, Inc. stock for Q4 2019, down 28% quarter-over-quarter.
  • 5 funds opened new Enzo Biochem, Inc. positions in Q4 2019 and 11 closed out, a net change of -6 holders.
  • The largest Enzo Biochem, Inc. buyer in Q4 2019 was Fondren Management, an estimated $1.11M added.
  • The largest Enzo Biochem, Inc. seller in Q4 2019 was EAM Investors, an estimated $734K sold.

Based on aggregated 13F filings for Q4 2019.